6 completed, 1 recruiting, 1 terminated, 1 unknown. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 6, Recruiting 1, Terminated 1, Unknown 1 |
Follow Somatoform Disorders: new trials by email Literature Review of Somatoform Disorders trials Research Report on Somatoform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders Ranquilon, Afobazole - Anxiety, Neurasthenia | Phase 4 | Recruiting | Valenta Pharm JSC | 250 | 2025-01-13 | 2025-07-08 |
| Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients Dexamethasone tapering dose, Dexamethasone physician choice - Early-stage Breast Cancer, Pain Syndrome | Phase 4 | Completed | Ottawa Hospital Research Institute | 124 | 2018-02-28 | 2020-01-09 |
| Treating Emotional Disorders in Primary Care With Psychological Techniques Cognitive Behavioral Treatment, Primary Care Treatment As Usual - Anxiety Disorders, Mood Disorders | Phase 4 | Completed | Psicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo | 1126 | 2014-01-14 | 2020-03-10 |
| Comparing Pregabalin and Placebo in Patients With Persistent Globus Sensation Pregabalin, Placebo - Globus Sensation | Phase 4 | Unknown | Universitaire Ziekenhuizen KU Leuven | 90 | 2010-03-12 | 2022-07-06 |
| Treatment Trial for Psychogenic Nonepileptic Seizures sertraline, CBT-ip, Combined (sertraline + CBT-ip) - Convulsion, Non-Epileptic, Conversion Disorder | Phase 4 | Completed | Rhode Island Hospital | 38 | 2008-09-01 | 2014-11-10 |
| CBT as an Adjunct to SRIs in the Treatment of BDD Cognitive Behavioral Therapy, Venlafaxine - Body Dysmorphic Disorder | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 17 | 2008-09-01 | 2017-03-09 |
| Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Levetiracetam - Body Dysmorphic Disorder | Phase 4 | Completed | Butler Hospital | 17 | 2004-12-01 | 2019-08-29 |
| Fluoxetine in Pediatric Body Dysmorphic Disorder Fluoxetine, Placebo - Body Dysmorphic Disorder | Phase 4 | Completed | Montefiore Medical Center | 43 | 2004-11-01 | 2018-04-27 |
| Treatments for Psychogenic Nonepileptic Seizures (NES) sertraline, placebo - Convulsion, Non-Epileptic, Conversion Disorder | Phase 4 | Completed | Rhode Island Hospital | 38 | 2003-12-01 | 2014-11-20 |
Anxiety Disorders (3) · Body Dysmorphic Disorders (3) · Conversion Disorder (2) · Depression (2) · Psychogenic Nonepileptic Seizures (2) · Seizures (2) · Stress Disorders, Post-Traumatic (2) · Adjustment Disorders (1) · Breast Neoplasms (1) · Depressive Disorder, Major (1) · Dissociative Disorders (1) · Dysthymic Disorder (1) · Generalized Anxiety Disorder (1) · Globus Sensation (1)
Mental Disorders (9) · Trauma and Stressor Related Disorders (3) · Behavior (2) · Behavioral Symptoms (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Stress Disorders, Traumatic (2) · Breast Diseases (1) · Conversion Disorder (1) · Depressive Disorder (1) · Neoplasms (1) · Neoplasms by Site (1)
Sertraline (2) · 2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole (1) · Acetaminophen (1) · Antidepressive Agents (1) · Cognitive Behavioral Therapy (1) · Fluoxetine (1) · GB-115 (1) · Levetiracetam (1) · Pregabalin (1) · Sleep (1) · Standard of Care (1) · Venlafaxine Hydrochloride (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1)
Rhode Island Hospital (2) · Butler Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · Montefiore Medical Center (1) · Ottawa Hospital Research Institute (1) · Psicofundación: Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicolo (1) · Universitaire Ziekenhuizen KU Leuven (1) · Valenta Pharm JSC (1)
United States (5) · Belgium (1) · Canada (1) · Russia (1) · Spain (1)
Eric Hollander, MD (2) · W. Curt LaFrance, Jr., MD, MPH (2) · Andrea Allen, PhD (1) · Antonio R Cano-Vindel, Professor (1) · Katharine A Phillips, M.D. (1) · Mark Clemons, MD (1)
PMID 18070841, PMID 18227745, PMID 19652140, PMID 20739647, PMID 24989152, PMID 33742240
K23NS045902 (1)